Welcome to our dedicated page for Chemours Co news (Ticker: CC), a resource for investors and traders seeking the latest updates and insights on Chemours Co stock.
Chemours Co (CC) delivers essential chemical solutions through its titanium technologies, fluoroproducts, and advanced performance materials. This news hub provides investors and industry professionals with timely updates on strategic developments shaping the company’s role in coatings, refrigeration, and industrial innovation.
Access authoritative coverage of Chemours’ financial announcements, product innovations, and operational milestones. Track critical updates including quarterly earnings, sustainability initiatives, and regulatory developments alongside analysis of market positioning in the chemical sector.
Our curated news collection features press releases on titanium dioxide advancements, breakthroughs in low-global-warming refrigerants like Opteon™, and partnerships driving next-generation materials for electric vehicles and data center cooling. Stay informed on leadership changes, patent filings, and industry recognition impacting Chemours’ global operations.
Bookmark this page for streamlined access to verified updates on CC’s technological advancements and financial performance. Combine real-time alerts with historical context to assess the company’s evolving market strategy.
DuPont, Corteva, and Chemours have reached a binding agreement to settle disputes related to Chemours' 2015 spin-off. This includes a cost-sharing arrangement for PFAS liabilities and an escrow account totaling $1 billion over eight years. DuPont and Corteva will split costs up to $2 billion, with Chemours contributing additional funds. The companies will also resolve PFOA litigation in Ohio for $83 million, with contributions from each firm. The agreement aims to provide security for shareholders against future environmental claims.
The Chemours Company (NYSE: CC) will announce its fourth quarter 2020 financial results after market close on February 11, 2021. A webcast conference call is scheduled for February 12, 2021, at 8:30 a.m. EST, which will be open to the public. This event offers stakeholders an opportunity to gain insights into Chemours' financial performance and future outlook. Chemours specializes in products essential for various industries including those in Fluoroproducts, Titanium Technologies, and Chemical Solutions.
The Chemours Company (NYSE: CC) commended Congress for passing the bipartisan American Innovation and Manufacturing Act (AIM Act), signed into law on December 27, 2020. The AIM Act is projected to provide $38 billion in economic benefits by 2027 and phase down hydrofluorocarbons (HFCs) across various industries. Chemours has developed low global warming potential (GWP) products and estimates that by 2025, its solutions will eliminate 325 million tons of CO2 equivalents. The company is prepared to support the transition to sustainable alternatives in the U.S. and globally.
The Chemours Company (NYSE: CC) has completed a private offering of $800 million in 5.750% senior unsecured notes due 2028. The proceeds will be used to repurchase existing 6.625% senior notes due 2023 and cover accrued interest. The offering was exempt from registration under the Securities Act, targeting qualified institutional buyers and non-U.S. persons. Chemours maintains a strong market presence in Titanium Technologies, Fluoroproducts, and Chemical Solutions, servicing over 3,700 customers worldwide.
The Chemours Company (NYSE: CC) announced the early tender results for its cash tender offer to purchase outstanding 6.625% senior notes due 2023, with valid tenders amounting to $781.35 million (86.06% of total notes). The early tender deadline was on November 25, 2020, and Chemours received requisite consents to amend the indenture governing the notes. The tender offer expires on December 10, 2020, and includes a total consideration of $1,017.94 per $1,000 principal amount for early tenders. The company expects early settlement on November 27, 2020.
The Chemours Company (NYSE: CC) announced the pricing of an $800 million private offering of 5.750% senior unsecured notes due 2028. The offering, exempt from registration under the Securities Act, will close around November 27, 2020. Proceeds will be used for the purchase and interest of Chemours' existing 6.625% senior notes due 2023 through a cash tender offer. This offering reflects Chemours' commitment to managing its debt and optimizing its capital structure.
The Chemours Company (NYSE: CC) announced a proposed private offering of $750 million in fixed-rate senior unsecured notes. The offering is exempt from the registration requirements of the Securities Act of 1933. Proceeds will be used for purchasing outstanding 6.625% senior notes due 2023 and, if necessary, redeeming any remaining notes post-tender offer. The notes are for qualified institutional buyers and non-U.S. persons. This offering aims to manage existing debt efficiently, impacting Chemours' financial structure.
The Chemours Company (NYSE: CC) has initiated a tender offer to buy back its 6.625% senior notes due 2023, totaling $907.91 million. The offer includes a consent solicitation for amendments to the indenture governing these notes. Early tendering holders can receive up to $1,017.94 per $1,000 principal amount. The offer expires on December 10, 2020. The completion is contingent on financing conditions and requires majority consent from note holders. This strategic move aims to enhance liquidity and potentially refinance obligations.
The Chemours Company (NYSE: CC) hosted its second annual global Corporate Responsibility Commitment (CRC) Day, with nearly 900 employees participating in over 53 events across 13 countries, totaling over 1,300 hours of service. This year saw a 60% increase in participation compared to last year. Events included supporting STEM education for underserved communities, environmental initiatives, and employee donation programs. The company's commitment to sustainability and diversity is highlighted through its ambitious goals that align with global standards.
The Chemours Company (NYSE: CC) reported third-quarter 2020 financial results, showcasing net sales of $1.2 billion and net income of $76 million, resulting in EPS of $0.46. Adjusted Net Income stood at $78 million with Adjusted EPS of $0.47. Despite a decrease in sales compared to the prior year, the company's Free Cash Flow improved to $252 million and they maintained a strong liquidity position of $1.7 billion. Chemours announced a dividend of $0.25 per share for Q4 2020. However, segments like Fluoroproducts and Chemical Solutions experienced declines in both volumes and prices, indicating ongoing market challenges.
